TipRanks
OncoZenge AB (DE:8LY)
FRANKFURT:8LY

Compare OncoZenge AB (8LY) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
OncoZenge AB
€0.59
€7.65M
-1.80
-30.62%
―
Oncopeptides AB
kr1.65
kr833.65M
-2.77
-57.48%
―
Isofol Medical AB
kr0.72
kr243.57M
-3.68
-3.74%
―
Elicera Therapeutics AB
kr5.35
kr184.86M
-7.87
-62.91%
―
Immunicum AB
kr5.77
kr402.17M
-3.55
-3.13%
―
Cantargia AB
kr4.07
kr429.68M
2.15
-46.83%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:8LY
OncoZenge AB
0.29
-0.14
-32.24%
SE:ONCO
Oncopeptides AB
2.11
-3.33
-61.24%
SE:ISOFOL
Isofol Medical AB
0.75
-0.04
-4.97%
SE:ELIC
Elicera Therapeutics AB
2.86
-4.21
-59.58%
SE:IMMU
Immunicum AB
6.20
-0.50
-7.46%
SE:CANTA
Cantargia AB
1.41
-1.38
-49.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts